Superoxide production in human neutrophils is enhanced by treatment with transmembrane peptides derived from human formyl peptide receptor

Journal of Biochemistry

Volumn 139, Issue 6, 2006, Pages 981-988

  Hayashi, Ryo ^a   Osada, Satoshi ^a   Yoshiki, Masahiro ^b   Sugiyama, Daisuke ^a   Fujita, Ichiro ^c   Hamasaki, Yuhei ^c   Kodama, Hiroaki ^a  

^a SAGA UNIVERSITY   (Japan)

^b Industrial Technology Center of Saga   (Japan)

^c SAGA UNIVERSITY   (Japan)

Author keywords

fMLP; Formyl peptide receptor; Human neutrophil; Priming; Transmembrane peptides

Indexed keywords

CALCIUM; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 1; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 2; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 3; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 4; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 5; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 6; FORMYLPEPTIDE RECEPTOR TRANSMEMBRANE PROTEIN 7; LIGAND; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; PEPTIDE FRAGMENT; SUPEROXIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL SURFACE; CIRCULAR DICHROISM; CONTROLLED STUDY; DIMERIZATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; HOST RESISTANCE; HUMAN; HUMAN CELL; NEUTROPHIL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; CALCIUM; CIRCULAR DICHROISM; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PEPTIDES; RECEPTORS, FORMYL PEPTIDE; SPECTROMETRY, FLUORESCENCE; SUPEROXIDES;

EID: 33746888275     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvj117     Document Type: Article

References (50)

1. Prossnitz, E.R. and Ye, R.D. (1997) The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74, 73-102
2. Boulay, F., Tardif, M., Brouchon, L., and Vignais, P. (1990) The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29, 11123-11133
3. Ye, R.D., Cavanagh, S.L., Quehenberger, O., Prossnitz, E.R., and Cochrane, C.G. (1992) Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem. Biophys. Res. Commun. 184, 582-589
4. Murphy, P.M., Ozcelik, T., Kenney, R.T., Tiffany, H.L., McDermott, D., and Francke, U. (1992) A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267, 7637-7643
5. Perez, H.D., Holmes, R., Vilander, L.R., Adams, R.R., Manzana, W., Jolley, D., and Andrews, W.H. (1993) Formyl peptide receptor chimeras define domains involved in ligand binding. J. Biol. Chem. 268, 2292-2295
6. Quehenberger, O., Prossnitz, E.R., Cavanagh, S.L., Cochrane, C.G., and Ye, R.D. (1993) Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 268, 18167-18175
7. Quehenberger, O., Pan, Z.K., Prossnitz, E.R., Cavanagh, S.L., Cochrane, C.G., and Ye, R.D. (1997) Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem. Biophys. Res. Commun. 238, 377-381
8. Lala, A., Gwinn, M., and Nardin, E.D. (1999) Human formyl peptide receptor function: Role of conserved and nonconserved charged residues. Eur. J. Biochem. 264, 495-499
9. Miettinen, H.M., Mills, J.S., Gripentrog, J.M., Dratz, E.A., Granger, B.L., and Jesaitis, A.J. (1997) The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J. Immunol. 159, 4045-4054
10. Mills, J.S., Miettinen, H.M., Cummings, D., and Jesaitis, A.J. (2000) Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu. J. Biol. Chem. 275, 39012-30917
11. Heldin, C.H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223
12. Lee, S.P., O'Dowd, B.F., and George, S.R. (2003) Homo- and hetero-oligomerization of G protein-coupled receptors. Life Sci. 74, 173-180
13. Schreiber, R.E., Prossnitz, E.R., Ye, R.D., Cochrane, C.G., and Bokoch, G.M. (1994) Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling: Mapping with receptor-derived peptides. J. Biol. Chem. 269, 326-331
14. Bommakanti, R.K., Klotz, K.N., Dratz, E.A., and Jesaitis, A.J. (1993) A carboxyl-terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein. J. Leukoc. Biol. 54, 572-577
15. i2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides. Biochemistry 34, 6720-6728
16. Tarasova, N.I., Rice, W.G., and Michejda C.J. (1999) Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions. J. Biol. Chem. 274, 34911-34915
17. Hebert, T.E., Moffett, S., Morello, J.P., Loisel, T.P., Bichet, D.G., Barret, C., and Bouvier, M. (1996) A peptide derived from a beta 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392
18. George, S.R., Lee, S.P., Varghese, G., Zeman, P.R., Seeman, P., Ng, G.K., and O'Dowd, B.F. (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem. 273, 30244-30248
19. George, S.R., Ng, G.K., Lee, S.P., Fan, T., Varghese, G., Wang, C., Deber, C.M., Seeman, P., and O'Dowd, B.F. (2003) Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivo. J. Pharmacol. Exp. Ther. 307, 481-489
20. Bollhage, R., Schmiedberger, M., and Grell, E. (1995) High-performance liquid chromatographic purification of extremely hydrophobic peptides: transmembrane segments. J. Chromatogr. 711, 181-186
21. Otaka, A., Ueda, S., Tomita, K., Yano, Y., Tamamura, H., Matsuzaki, K., and Fujii, N. (2004) Facile synthesis of membrane-embedded peptides utilizing lipid bilayer-assisted chemical ligation. Chem. Commun. 7, 1722-1723
22. Miyazaki, M., Kodama, H., Fujita, I., Hamasaki, Y., Miyazaki, S., and Kondo, M. (1995) Dimeric chemotactic peptides discriminate between chemotaxis and superoxide production of human neutrophils. J. Biochem. 117, 489-494
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450
24. Wimley, W.C. and White, S.H. (2000) Designing transmembrane α-helices that insert spontaneously. Biochemistry 39, 4432-4442
25. Zhang, P., Johson, P.S., Zollner, C., Wang, W., Montes, A.E., Seidleck, B.K., Blaschak, C.J., and Surratt, C.K. (1999) Mutation of human μ opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. Mol. Brain. Res. 72, 195-204
26. Yamaguchi, H., Kodama, H., Osada, S., Jelokhani-Niaraki, M., Kato, F., and Kondo, M. (2002) The position of Aib residues defines the antimicrobial activity of Aib-containing peptides. Bull. Chem. Soc. Jpn. 75, 1563-1568
27. Yamaguchi, H., Kodama, H., Osada, S., Kato, F., Jelokhaniniaraki, M., and Kondo, M. (2003) Effect of α,α-dialkyl amino acids on the protease resistance of peptides. Biosci Biotechnol Biochem. 67, 2269-2272
28. Yamaguchi, H., Jelokhani-Niaraki, M., and Kodama, H. (2004) Second transmembrane domain of human uncoupling protein 2 is essential for its anion channel formation. FEBS Lett. 577, 299-304
29. Hara, T., Kodama, H., Higashimoto, Y., Yamaguchi, H., Jelokhani-Niaraki, M., Ehara, T., and Kondo, M. (2001) Side chain effect on ion channel characters of Aib rich peptides. J. Biochem. 130, 749-755
30. Higashimoto, Y., Kodama, H., Jelokhani-Niaraki, M., Kato, F., and Kondo, M. (1999) Structure-function relationship of model Aib-containing peptides as ion transfer intermembrane templates. J. Biochem. 125, 705-712
31. Condliffe, A.M., Kitchen, E., and Chilvers, E.R. (1998) Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin. Sci. 94, 461-471
32. Swain, S.D., Rohn, T.T., and Quinn, M.T. (2002) Neutrophil priming in host defense: role of oxidants as priming agents. Antioxid. Redox Signal. 4, 69-83
33. 2+ signal. Cell Calcium 11, 655-663
34. Lazarova, T., Brewin, K.A., Stoeber, K., and Robinson, C.R. (2004) Characterization of peptides corresponding to the seven transmembrane domains of human adenosine A2a receptor. Biochemistry 43, 12945-12954
35. Nakamura, H., Sano, A., and Matsuura, K. (1998) Determination of critical micelle concentration of anionic surfactants by capillary electrophoresis using 2-naphthalenemethanol as a marker for micelle formation. Anal. Sci. 14, 379-382
36. Unger, V.M., Hargrave, P.A., Baldwin, J.M., and Schertler, G.F. (1997) Arrangement of rhodopsin transmembrane alpha-helices. Nature 389, 203-206
37. Gripentrog, J.M., Kantele, K.P., Jesaitis, A.J., and Miettinen, H.M. (2003) Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor. J. Immunol. 171, 3187-3193
38. Staudinger, R., Phogat, S.K., Xiao, X., Wang, X., Dimitrov, D.S., and Zolla-Pazner, S. (2003) Evidence for CD4-enchanced signaling through the chemokine receptor CCR5. J. Biol. Chem. 278, 10389-10392
39. Liu, F., Wan, Q., Pristupa, Z.B., Yu, X.M., Wang, Y.T., and Niznik, H.B. (2000) Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403, 274-280
40. Pei, L., Lee, F.J.S., Moszczynska, A., Vukusic, B., and Liu, F. (2004) Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J. Neurosci. 24, 1149-1158
41. 2 receptor regulation of AMPA receptor-mediated excitotoxicity. J. Neurosci. 25, 4385-4395
42. Lorenz, D., Wiesner, B., Zipper, J., Winkler, A., Krause, E., Beyermann, M., Lindau, M., and Bienert, M. (1998) Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J. Gen. Physiol. 112, 577-591
43. Aridor, M., Traub, L.M., and Sagi-Eisenberg, R. (1990) Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J. Cell Biol. 111, 909-917
44. Takesono, A., Cismowski, M.J., Ribas, C., Bernard, M., Chung, P., Hazard, S., Duzic, E., and Lanier, S.M. (1999) Receptor-independent activators of heterotrimeric G-protein signaling pathways. J. Biol. Chem. 274, 33202-33205
45. Kinkel, T.H., Pabst, M.J., Suzuki, H., Guthrie, L.A., Forehand, J.R., Phillips, W.A., and Johnston Jr, R.B. (1987) Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. Implications for regulation of the respiratory burst. J. Biol. Chem. 262, 12589-12596
46. Breit, A., Lagacé, M., and Michel Bouvier, M. (2004) Hetero-oligomerization between β2- and β3-adrenergic receptors generates α-adrenergic signaling unit with distinct functional properties. J. Biol. Chem. 279, 28756-28765
47. Rios, C.D., Jordan, B.A., Gomes, I., and Devi, L.A. (2001) G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther. 92, 71-87
48. Chidiac, P., Hebert, T.E., Valiquette, M., Dennis, M., and Bouvier, M. (1994) Inverse agonist activity of beta-adrenergic antagonists. Mol. Pharmacol. 45, 490-199
49. Waller, A., Pipkorn, D., Sutton, K.L., Linderman, J.J., and Omann, G.M. (2001) Validation of flow cytometric competitive binding protocols and characterization of fluorescently labeled ligands. Cytometry 45, 102-114
50. Waller, A., Sutton, K.L., Kinzer-Ursem, T.L., Absood, A., Traynor, J.R., Linderman, J.J., and Omann, G.M. (2004) Receptor binding kinetics and cellular responses of six N-formyl peptide agonists in human neutrophils. Biochemistry 43, 8204-8216